Colombia’s president signs law to strengthen pharmaceutical sector
Colombia’s vulnerability to shortages and its dependence on other countries for supplies was exposed during the Covid-19 pandemic.
Pricing and Market Access
Casgevy: Launch sequence and price analysis of the first marketed CRISPR therapy
The US Biosecure Act threatens to destabilise the pharmaceutical industry
UK’s antibiotic subscription funding model – a route to market sustainability?
Ukraine: a market access review over two years of war
AIFA’s horizon scanning 2024 predictions suggest an influx of ATMPs
The privileged status of orphan medicines in Germany
India sees insignificant revision to price ceiling in 2024
